X
Record #2208

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

Publisher
Elsevier
Original paper date
Nov 14, 2007
Institution
Geneva University Hospital,Geneva, Switzerland, European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium · Swiss Group for Clinical Cancer Research (SAKK), Berne, Switzerland · Duke Institute for Genome Sciences and Policy, and Duke University Medical Center, Durham, NC, USA · Swiss Institute for Experimental Cancer Research (ISREC), National Centre of Competence in Research (NCCR), Epalinges, Switzerland · Swiss Institute for Bioinformatics (SIB), Lausanne, Switzerland · Bergonié Institute, Bordeaux, France · René Gauducheau Centre, Nantes, France · René Huguenin Centre, St-Cloud, France · Paul Strauss Centre, Strasbourg, France · Paul Lamarque Centre, Montpellier, France · Medical University, Gdansk, Poland · Henri Becquerel Centre, Rouen, France · Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh University, Edinburgh, UK · Swedish Breast Cancer Group (SweBCG), Karolinska Institute and Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden · University of St Andrews, Scotland, UK
Open access
No
Article type
Clinical Study
Broad categories
(BLS) Genetics(HSC) Medicine - Oncology(HSC) Medicine - Pharmacology
Notes from Retraction Watch

Finding of Research Misconduct for Anil Potti: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687471/

Citation lifecycle

How this paper is being cited

Pre-retraction
64
Same day
0
Post-retraction
96
% post-retraction
60.0%
~23.7 citations/yr before retraction · ~5.9 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse